cis-Resveratrol Reduces Male-Specific Anxiety-Like Behaviour and Facilitates Fear Extinction via mRNA Translation
Authors:
- Brandon RodrigueBRBrandon Rodrigue
- Jared VanderZwaagJVJared VanderZwaag
- Amanda CarrollACAmanda Carroll
- Keagan CanningKCKeagan Canning
- Michael ParkhillMPMichael Parkhill
- Tori RockTRTori Rock
- Mathew SajishMSMathew Sajish
- Paul SchimmelPSPaul Schimmel
- Nahum SonenbergNSNahum Sonenberg
- Marie-Eve TremblayMTMarie-Eve Tremblay
Preprint
- 21 September 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Anxiety disorders are associated with dysfunction of amygdala circuits and altered mitochondrial homeostasis. Resveratrol (RSV), a naturally occurring polyphenol with antioxidant properties, produces anxiolytic-like effects in preclinical models. However, most studies have examined trans -RSV, whereas the neurobehavioural effects of its cis isomer remain poorly characterized. RSV can activate mechanistic/mammalian target of rapamycin complex 1 (mTORC1), which regulates cap-dependent mRNA translation through eukaryotic initiation factor 4E-binding proteins (4E-BPs), but it is unknown whether this pathway mediates its behavioural effects. Here, we investigated the behavioural and structural effects of chronic cis -RSV treatment in wild-type mice and mice lacking 4E-BP1 and 4E-BP2, Eif4ebp1 and Eif4ebp2 double-knockout mice ( Eif4ebp1/2 −/− ). Anxiety-like and stress-coping behaviours were assessed using the open-field test, elevated plus maze, light–dark box, and forced swim test. We evaluated fear learning and extinction using auditory fear-conditioning and extinction paradigms and examined basolateral amygdala (BLA) ultrastructure by focused ion beam-scanning electron microscopy. In males, cis -RSV reduced anxiety-like behaviour and enhanced fear-extinction retention in wild-type mice, but not in Eif4ebp1/2 −/− mice, indicating that these effects require 4E-BP-regulated mRNA translation. In females, cis -RSV produced no anxiolytic-like effects and modestly increased anxiety-like behaviour in some measures. Cis -RSV did not affect forced swim behaviour in either sex. In males, cis -RSV reduced BLA dendritic spine density independently of genotype but produced only modest changes in mitochondrial ultrastructure. Together, these findings identify sex-dependent effects of cis -RSV on anxiety-like behaviour and fear extinction and demonstrate that its behavioural, but not synaptic structural, effects require 4E-BP-regulated mRNA translation.Keywords
All Related Versions
This publication has 85 references indexed in Scilit:
- Anxiety DisordersJAMA, 2022
- Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent LiteratureCurrent Psychiatry Reports, 2022
- Investigating Microglial Ultrastructural Alterations and Intimate Relationships with Neuronal Stress, Dystrophy, and Degeneration in Mouse Models of Alzheimer’s Disease2022
- The Antidepressant Effects of Resveratrol are Accompanied by the Attenuation of Dendrite/Dendritic Spine Loss and the Upregulation of BDNF/p-cofilin1 Levels in Chronic Restraint MiceNeurochemical Research, 2021
- Towards resolving the enigma of the dichotomy of resveratrol: cis- and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activationGeroScience, 2020
- Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related DisordersJAMA Psychiatry, 2020
- Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant DefensesNeurotoxicity Research, 2018
- Inhibition of protein synthesis or mTOR in the basolateral amygdala blocks retrieval-induced memory strengtheningJournal of Neural Transmission, 2013
- Disrupted Amygdalar Subregion Functional Connectivity and Evidence of a Compensatory Network in Generalized Anxiety DisorderArchives of General Psychiatry, 2009
- Stereospecific determination of cis‐ and trans‐resveratrol in rat plasma by HPLC: application to pharmacokinetic studiesBiomedical Chromatography, 2007